Mindoo raises €5M for AI healthcare workforce platform

Mindoo offers configurable, voice-first AI agents designed to serve as scalable workforce extensions, enabling hospital teams to define and automate repetitive workflows.
Mindoo raises €5M for AI healthcare workforce platform

The European platform for deploying safe and governed agentic workflows in healthcare, Mindoo, has secured €5 million in seed financing from 6DC, Syndicate One and a group of strategic angel investors.

Healthcare organisations are increasingly balancing limited staffing with growing demand for care, leaving some workflows unfinished or not recorded because teams do not have the capacity to manage them.

Mindoo addresses this by providing configurable AI agents that hospital teams use to handle structured intake, documentation drafting, follow-up interactions and front-desk communication within a single platform.

The company currently offers four core agents that hospitals can adapt to their own protocols, languages, and speciality workflows: a receptionist agent for routine patient communication and registration, a pre-visit agent for structured intake and medical history, a scribe agent for drafting notes, letters, and orders, and a follow-up agent for post-visit communication and care pathways.

We learned very quickly that workflows in healthcare cannot be adapted to a product. The product has to adapt to existing workflows. That is why Mindoo lets hospital teams configure and run their own agents, so automation fits naturally into how they already work,

explained Gauthier Willemse, CEO and co-founder of Mindoo.

Mindoo is currently deployed in hospitals in Belgium and Germany and is designed to integrate with modern EHR systems. The company plans to expand into the Netherlands and France as additional reference sites become operational.

The investment supports Mindoo’s plan to provide hospitals and practices with a scalable AI workforce layer that can take on routine tasks, ease pressure on clinical teams, and keep organisations in control of their workflows.

The funding will be used to develop the platform further, bring its four core agents to production readiness across multiple specialities, and expand the team across engineering, clinical, and deployment functions.

Follow the developments in the technology world. What would you like us to deliver to you?
Your subscription registration has been successfully created.